Trial intelligence / Profile preview

Mifepristone vs Osmotic Dilators for Cervical Preparation Prior to D&E

NCT02679092Withdrawn

Sponsor
Stanford University
Start
Apr 2016
Primary completion
Feb 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label trial of mifepristone in abortion (4 arms), sponsored by Stanford University. Primary endpoint: Procedure Time. Planned start Apr 2016; status: withdrawn.

02

Drugs

mifepristone
03

Conditions

abortion

Beyond the preview

Go deeper on NCT02679092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02679092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call